Skip to main content

Table 2 Characteristics of surviving infants with or without Oxygen Dependancy at 36 Weeks PCA

From: Elevated platelet-derived growth factor-BB concentrations in premature neonates who develop chronic lung disease

 

Off Oxygen at 36 weeks (n = 28)

Oxygen at 36 weeks PCA (n = 16)

P Value

Birth Weight

1011 ± 43

741 ± 38

<0.001

Gestation

27.1 ± 0.3

26.1 ± 0.4

0.057

Surfactant

27 (96)

16 (100)

1.00

Prenatal Steroids

22 (78)

11 (69)

0.492

Uu isolated

13 (46)

5 (31)

0.324

PDA

13 (46)

8 (50)

0.907

Indomethacin1

25 (89)

16 (100)

0.290

Duration IMV (days)

15 ± 2

53 ± 8

<0.001

Duration O2 (days)

30 ± 4

106 ± 13

<0.001

Postnatal Steroids

14 (50)

16 (100)

<0.001

Age Steroids Stated

10.0 ± 1.2

12.8 ± 2.1

0.282

PH

3 (11)

4 (25)

0.236

IVH

6 (21)

8 (50)

0.503

  1. Data are presented as Mean ± SEM or number with percentage in parenthesis 1Indomethacin was used prophylactically in most cases Uu Ureaplasma urealyticum PH Pulmonary hemorrhage PDA Patent ductus arteriosus IVH Intraventricular hemorrhage